Impact of Comorbidity Burden in Treatment and Outcome of Older Patients with Indolent Non-Hodgkin Lymphomas

被引：0
|
作者：
Gritti, Giuseppe [1 ]
Stefanoni, Paola [2 ]
Boschini, Cristina [2 ]
Rossi, Andrea [2 ]
Barbui, Anna Maria [1 ]
Rambaldi, Alessandro
机构：
[1] Hosp Papa Giovanni XXIII, Dept Hematol, Bergamo, Italy
[2] Azienda Osped Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment of indolent non-Hodgkin's Lymphomas
    Moreno Nogueira, J. A.
    Casas Fernandez de Tejerina, A.
    Moreno Rey, C.
    REVISTA CLINICA ESPANOLA, 2009, 209 (02): : 82 - 87
  • [2] Cladribine for the treatment of indolent non-Hodgkin's lymphomas
    Hoffman, MA
    SEMINARS IN HEMATOLOGY, 1996, 33 (01) : 40 - 44
  • [3] Erythropoiesis in patients with aggressive and indolent non-Hodgkin's lymphomas
    Domnikova, NP
    Degtyareva, VV
    Nepomnyashchikh, LM
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2004, 138 (06) : 593 - 597
  • [4] Erythropoiesis in patients with aggressive and indolent non-Hodgkin’s lymphomas
    N. P. Domnikova
    V. V. Degtyareva
    L. M. Nepomnyashchikh
    Bulletin of Experimental Biology and Medicine, 2004, 138
  • [5] Reappraising the timing of transplant for indolent non-Hodgkin lymphomas
    Capria, Saveria
    Barberi, Walter
    Perrone, Salvatore
    Ferretti, Antonietta
    Salaroli, Adriano
    Annechini, Giorgia
    D'Elia, Gianna Maria
    Foa, Robin
    Pulsoni, Alessandro
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (10) : 951 - 964
  • [6] Management of histologically indolent non-Hodgkin's lymphomas
    SolalCeligny, P
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (04): : 669 - 687
  • [7] Developing a Comorbidity Risk Prediction Model for Older Adults with Indolent Non-Hodgkin Lymphoma
    Hester, Laura
    Brookhart, M. Alan
    Sturmer, Til
    Lund, Jennifer
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 209 - 210
  • [8] Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
    Minson, Adrian
    Tam, Constantine
    Dickinson, Michael
    Seymour, John F.
    CANCERS, 2022, 14 (05)
  • [9] Effective treatment of indolent non-Hodgkin's lymphomas with mitoxantrone, chlorambucil and prednisone
    Wöhrer, S
    Raderer, M
    Kaufmann, H
    Hejna, M
    Chott, A
    Zielinski, CC
    Drach, J
    ONKOLOGIE, 2005, 28 (02): : 73 - 78
  • [10] Racial disparities in the survival of patients with indolent non-Hodgkin lymphomas in the United States
    Vaughn, John L.
    Spies, Daniela
    Xavier, Ana C.
    Epperla, Narendranath
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : 816 - 822
12345